Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

01 mai 2020 09h00 HE | Source: Quotient Limited

Quotient Limited Announces CE Mark for its SARS-CoV-2 (COVID-19) Antibody Microarray

JERSEY, Channel Islands, May 01, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, Switzerland, today announced...
27 avr. 2020 16h05 HE | Source: Quotient Limited

Quotient Limited Announces SARS-CoV-2 (COVID-19) Antibody Test Final Performance Data

JERSEY, Channel Islands, April 27, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, Switzerland, today reported...
21 avr. 2020 16h05 HE | Source: Quotient Limited

Quotient Limited Announces SARS-CoV-2 (COVID-19) Antibody Test Performance Update

JERSEY, Channel Islands, April 21, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, Switzerland, today reported...